Today Domo (Nasdaq: DOMO) announced that management will present at the 2025 Cantor Fitzgerald Global Technology Conference on Tuesday, March 11, 2025 at 3:00pm ET. A live webcast of Domo's ...

Cantor Fitzgerald analyst Troy Jensen maintained a Buy rating on Stratasys (SSYS – Research Report) yesterday and set a price target of $15.00.

Cantor Fitzgerald raised the firm’s price target on Stratasys (SSYS) to $15 from $12 and keeps an Overweight rating on the shares ahead of the ...

Monness Crespi & Hardt upgraded Oracle from a sell to a neutral rating, reflecting shifting analyst sentiment. Other firms ...

Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of Teladoc Health in a research report issued on Thursday, February 27th. Cantor Fitzgerald ...

Rosenblatt Securities restated their buy rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research note released on Monday,Benzinga reports. The firm currently has a $10.00 price ...

Billionaire Giancarlo Devasini of Tether wants to maintain the stablecoin’s freedoms; his rival, Jeremy Allaire of Circle, is ...

We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now. In this article, we are going to take a look at ...

Fintel reports that on February 26, 2025, Cantor Fitzgerald downgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) ...

The former chair of the Wall Street firm abandoned his post as he was confirmed as the United States Commerce Secretary.

Tuesday, Vera Therapeutics shares received a continued vote of confidence from Cantor Fitzgerald, as the firm reiterated its Overweight rating and $107.00 price target on the biotechnology company’s ...